| The longitudinal relationship between fatigue, depression, anxiety, disability, and adherence with cognitive status in patients with early multiple sclerosis treated with interferon beta-1a
|
| Author(s): Hanne van Ballegooijen, Karin van der Hiele, Christian Enzinger, Gert de Voer, Leo H. Visser, on behalf of the CONFIDENCE Study Group |
| Affiliations(s): IQVIA Netherlands, Real World Evidence, Netherlands
b
Department of Psychology, Health, Medical and Neuropsychology Unit, Leiden University, Leiden, Netherlands
c
Medical University of Graz, Graz, Austria
d
Merck BV, Schiphol-Rijk, The Netherlands, an affiliate of Merck KGaA, Germany
e
St Elisabeth Tweesteden Hospital, Tilburg, the Netherlands |
Publication(s): eNeurologicalSci,
Volume 28,
2022,
100409,
ISSN 2405-6502,
https://doi.org/10.1016/j.ensci.2022.100409.
(https://www.sciencedirect.com/science/article/pii/S2405650222000181)
|
| Document Type(s): Article, |
| Countries: Austria, Belgium, Netherlands , Slovakia, |
| Click here for the abstract |
C:
Y: |
Drug safety, Drug Utlization Study, Neurological disorders,
2022 |
|
L:
A: |
English
Clinical setting: hospital, clinical setting: Secondary care, Epidemiological study, Population Based Study, Prospective study, |
|
 |
| |
| |
| Validation of safety outcomes in routinely collected data: lessons learned from a multinational post-approval safety study
|
| Author(s): Arena PJ, Huang K, Löfling L, Bahmanyar S, Mo J, Schachterle SE, Nunes AP, Smits E, Juuti R, Hoti F, Korhonen P, Adelborg K, Sundbøll J, Rasmussen TR, Løkke A, Ehrenstein V.
|
| Affiliations(s): "Pfizer Inc., New York, New York, United States of America.
Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, California, United States of America.
EPID Research (an IQVIA company), Espoo, Finland."
|
Publication(s): Pharmacoepidemiol Drug Saf. 2022 Dec 10. doi: 10.1002/pds.5582
|
| Document Type(s): Article, |
| Countries: Denmark, Finland, Netherlands , Sweden, USA, |
| Click here for the abstract |
C:
Y: |
Database Validity and methodology, Drug safety, Oncology,
2022 |
|
L:
A: |
English
Clinical setting: hospital, Clinical setting: Primary care, clinical setting: Secondary care, Retrospective database analysis, |
|
|
| |
| |
| Concerns, quality of life, access to care and productivity of the general population during the first 8 weeks of the coronavirus lockdown in Belgium and the Netherlands |
| Author(s): Hanne van Ballegooijen 1, Lucas Goossens 2, Ralph H Bruin 3, Renée Michels 3, Marieke Krol 3
|
| Affiliations(s): 1IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. hanne.vanballegooijen@iqvia.com.
2Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands.
3IQVIA, Herikerbergweg 314, 1101 CT, Amsterdam, The Netherlands. |
Publication(s): 1 IQVIA, Herikerbergweg 314, 1101 CT Amsterdam, The Netherlands. 2 Erasmus University Rotterdam, Erasmus School of Health Policy & Management, Rotterdam, The Netherlands
BMC Health Services Research (2021) 21:227
PMID: 33712010 PMCID: PMC7953179 DOI: 10.1186/s12913-021-06240-7
|
| Document Type(s): Article, |
| Countries: Netherlands , |
| Click here for the abstract |
C:
Y: |
Health economics, Health status & patient reported outcomes, Immunology and Vaccination,
2021 |
|
L:
A: |
English
Observational study, Patient questionnaire, Population Based Study, Public Health, Quality of life, Survey research, |
|
|
| |
| |
| GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data. |
| Author(s): Divino V, Boye KS, Lebrec J, DeKoven M, Norrbacka K |
| Affiliations(s): IQVIA, Eli Lilly |
Publication(s): Journal. Diabetes Ther. 2019 Jun;10(3):1067-1088.
|
| Document Type(s): Article, |
| Countries: Belgium, Canada, France, Germany, Italy, Netherlands , |
| Click here for the abstract |
C:
Y: |
Diabetes,
2019 |
|
L:
A: |
English
Retrospective database analysis, |
|
|
| |
| |
|
|
